|
| View:
Latest News | Top Stories |
|
| Sunday, Dec 6, 2009 |
|
| · | [external] Better Biotech Buy: Celgene or Genzyme?
at Motley Fool -
Sun 12:11 am ET |
|
| Saturday, Dec 5, 2009 |
|
| · | Cyclacel Reports Phase 2 Sapacitabine Data in Acute Myeloid Leukemia and Myelodysplastic Syndromes at 2009 ASH Annual Meeting
GlobeNewswire -
Sat 10:00 am ET |
|
| Friday, Dec 4, 2009 |
|
| · | [external] Cramer's 'Mad Money' Recap: How to Play the Surprising Jobs Report (Update 1)
at TheStreet.com -
Fri 6:39 pm ET |
|
| · | The Coming Week's Game Plan: Blood, Tech and Jeers
at CNBC -
Fri 6:21 pm ET |
|
| · | [external] NASDAQ warns Discovery Laboratories on stock price
at bizjournals.com -
Fri 6:05 pm ET |
|
| · | Pulmo BioTech Inc. Announces Further Details of the Background to Its Previously Announced Letter of Intent Regarding the Proposed License of Its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) to the Polish Company, Biotechno
Marketwire -
Fri 5:36 pm ET |
|
| · | Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Hemispherx Biopharma, Inc. (AMEX: HEB)
Marketwire -
Fri 4:27 pm ET |
|
| · | Discovery Labs Receives Nasdaq Notification Related to Minimum Bid Price
GlobeNewswire -
Fri 4:15 pm ET |
|
| · | Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference
PR Newswire -
Fri 4:00 pm ET |
|
| · | [external] Our Final Offer (Maybe)! That's a FACT!
at Motley Fool -
Fri 3:29 pm ET |
|
| · | Significant Deal for AZN
Zacks.com -
Fri 3:02 pm ET |
|
| · | Ziopharm Oncology to raise $45.2M in public offer
AP -
Fri 2:23 pm ET |
|
| · | BioTime CEO Dr. Michael West to Ring The Opening Bell at the New York Stock Exchange
Business Wire -
Fri 2:01 pm ET |
|
| · | PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop
PR Newswire -
Fri 1:30 pm ET |
|
| · | Celgene's ASH Monday
at CNBC -
Fri 11:20 am ET |
|
| · | PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop
PR Newswire -
Fri 11:01 am ET |
|
| · | ZIOPHARM Prices Public Offering
Business Wire -
Fri 9:31 am ET |
|
| · | [external] Hemispherx Needs to Face Reality
at TheStreet.com -
Fri 9:30 am ET |
|
| · | [external] Hemispherx Upbeat Despite FDA setback
at TheStreet.com -
Fri 9:30 am ET |
|
| · | Skymark Research Initiates Independent Research Coverage on Protalix Biotherapeutics, Inc.
GlobeNewswire -
Fri 9:00 am ET |
|
|
More Latest News...
|
